Results 221 to 230 of about 432,722 (348)

Kinetic Spectrophotometric Determination Of Ramipril In Commercial Dosage Forms

open access: green, 2008
Nafisur Rahman   +2 more
openalex   +1 more source

Basilar Artery Occlusion Stroke Managed With Tenecteplase Versus Alteplase Before Endovascular Treatment (BAO‐TNK)

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To compare the effectiveness and safety of tenecteplase (TNK) versus alteplase (TPA) in patients with basilar artery occlusion prior to endovascular treatment (EVT). Methods In this retrospective multicenter study (BAO‐TNK), we analyzed consecutive BAO patients from 14 U.S.
Rahul R. Karamchandani   +38 more
wiley   +1 more source

In vitro–in vivo correlation from lactide-co-glycolide polymeric dosage forms [PDF]

open access: yes, 2014
Jabar A. Faraj   +3 more
core   +1 more source

Bioavailability Enhancement and Formulation Technologies of Oral Mucosal Dosage Forms: A Review. [PDF]

open access: yesPharmaceutics
Bácskay I   +10 more
europepmc   +1 more source

Development of gastroretentive dosage form

open access: yesEuropean Journal of Pharmaceutical Sciences, 1996
Whitehead, L, Fell, JT, Collett, JH.
openaire   +2 more sources

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin   +2 more
wiley   +1 more source

Search of new excipients in technology of farmaceutical drugs [PDF]

open access: yes, 2018
Ananieva, V. V.   +2 more
core  

Home - About - Disclaimer - Privacy